Faslodex

Type: Product
Name: Faslodex
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Array BioPharma, Inc. (ARRY) Appoints Victor Sandor, M.D., As Chief Medical Officer

BOULDER, Colo., Sept. 11, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients with cancer, today announced ... [Published FierceBiotech - Sep 19 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

Court Report - September 2014 #4

About Court Report:  Each week we will report briefly on recently filed biotech and pharma cases .Millennium Pharmaceuticals Inc. v. Glenmark Pharmaceuticals Ltd. et al.1:14-cv-01156; filed September 10, 2014 in the District Court of Delaware• Plaintiff:  ... [Published JD Supra - Sep 15 2014]
First reported Sep 11 2014 - Updated Sep 12 2014 - 1 reports

Array BioPharma : Appoints Victor Sandor, M.D., As Chief Medical Officer

BOULDER, Colo., Sept. 11, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients with cancer, today announced ... [Published 4 Traders - Sep 11 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

The 4 Companies Teaming Up For A New Tool To Fight Cancer

A new tool in the fight against cancer is on the horizon.Big pharma and one relatively small company are teaming up to develop a master test that will help doctors pick a combination of drugs tailored to the individual patient’s condition.Illumina (NASDAQ: ... [Published Benzinga.com - Aug 25 2014]
First reported Aug 19 2014 - Updated Aug 20 2014 - 1 reports

Pfizer Submits Palbociclib Marketing Application to the FDA

Pfizer Inc. ( PFE - Analyst Report ) announced that it has submitted the marketing application for its oncology candidate, palbociclib, to the FDA. The company is looking to get the candidate approved in combination with Novartis’ ( NVS - Analyst ... [Published Zacks.com - Aug 19 2014]
First reported May 13 2014 - Updated May 13 2014 - 1 reports

Human medicines European public assessment report (EPAR): Faslodex, fulvestrant, Revision: 12, Authorised

First reported Apr 28 2014 - Updated Apr 28 2014 - 2 reports

Pfizer Confirms AstraZeneca Interest

NEW YORK (The Deal) -- New York pharmaceuticals giant Pfizer on Monday said it was considering making a renewed run at AstraZeneca AZN to strengthen its cancer treatments after a failed January approach and as rivals successfully expand their oncology ... [Published The Street Latest - Apr 28 2014]

Quotes

"I am pleased to join the Array team at such an exciting time in the company's evolution," said Dr. Sandor. "In addition to the impressive portfolio of clinical-stage assets in development by Array's partners, I look forward to focusing on the development of binimetinib and filanesib, which each target patient populations with significant unmet medical need."
Infringement of U S Patent Nos. 8,017,615 ( "Low Hygroscopic Aripiprazole Drug Substance and Process for the Preparation Thereof" issued September 13, 2011), 8,580,796 (same title, issued November 12, 2013), and 8,642,760 (same title, issued February 4, 2014) following a Paragraph...
"I view a takeover of AstraZeneca by the U S drug company exceptionally skeptically" wrote Deutsche Bank AG analyst Mark Clark in a note. He has a hold rating on AstraZeneca shares...

More Content

All (10) | News (8) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Array BioPharma, Inc. (ARRY) Appoints Victor Sa... [Published FierceBiotech - Sep 19 2014]
Court Report - September 2014 #4 [Published JD Supra - Sep 15 2014]
Array BioPharma : Appoints Victor Sandor, M.D.,... [Published 4 Traders - Sep 11 2014]
The 4 Companies Teaming Up For A New Tool To Fi... [Published Benzinga.com - Aug 25 2014]
Pfizer Submits Palbociclib Marketing Applicatio... [Published Zacks.com - Aug 19 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - May 13 2014]
Pfizer Confirms AstraZeneca Interest [Published The Street Latest - Apr 28 2014]
Pfizer Confirms It Wants To Do A Blockbuster Ta... [Published Clusterstock - Apr 28 2014]
Combination treatment with strontium for the pr... [Published PharmCast - Jan 22 2014]
Higher Dose of Faslodex Effective in Advanced B... [Published BioPortfolio - Dec 30 2013]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - May 13 2014]
Pfizer Confirms It Wants To Do A Blockbuster Ta... [Published Clusterstock - Apr 28 2014]
Here's a big, juicy M&A story to get the market excited on a Monday morning. Pharmaceutical giant Pfizer has said in a new press release that it has approached UK pharmacuetical maker AstraZeneca about a $100 billion takeover offer, but that AstraZeneca ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.